ERBB2 and breast cancer: Interestingly, the expression of RNF114 is significantly higher in HER2-positive BC, and knockdown of RNF114 significantly inhibits cell proliferation, migration, invasiveness, and autophagy in HER2-positive BC cells, revealing the potent roles of RNF114 in HER2-positive BC (Figure 2).